IGF-1 is the second signal that drives most of the effects people link to GH muscle protein building, fat metabolism, and tissue repair
Robust Phase 2/3 studies are still lacking and most of the evidence remains preclinical
This route opens the door for more people to access these powerful therapies safely and consistently under medical guidance
Every patient undergoes a thorough evaluation before approval, ensuring their treatment is safe
Preclinical studies have found that Ex-4 significantly upregulates Sirt3 expression in glioblastoma by activating the GLP-1R, which subsequently inhibits the growth, migration, invasion, and epithelial-mesenchymal transition of glioma cells [87]
Glucagon-like peptide 1 receptor (GLP-1R), on the other hand, is primarily expressed in the pancreas, gut, central nervous system, and also found in other tissues like the heart, kidneys, and lungs